Based on recent data, Enzo Biochem, Inc. (ENZ) shows an Average True Range (ATR) of 0.06 and an Enterprise Value of -3.76M. Its average trading volume over the past 3 months is N/A, indicating liquidity. These fundamental metrics provide insight into ENZ's underlying financial health and market activity.
| ATR | 0.06 |
| Enterprise Value | -3.76M |
| Avg Vol (3 Months) | - |
| Avg Vol (10 Days) | - |
Enzo Biochem, Inc. (ENZ) technical indicators as of February 6, 2026: the SMA 20 is -14.15%, SMA 50 at -29.35%, and SMA 200 at -61.9%. The RSI 14 value is 40.43, suggesting its current momentum. These technical analysis signals help assess ENZ's price trends and potential future movements.
| SMA 20 | -14.15% |
| SMA 50 | -29.35% |
| SMA 200 | -61.9% |
| RSI 14 | 40.43 |
Enzo Biochem, Inc. (ENZ) stock performance overview as of February 6, 2026: The 52-week high is $0.575 (currently -73.02% below), and the 52-week low is $0.252 (currently 24.52% above). Over the past year, ENZ's performance is N/A, compared to the S&P 500's 8.96% change.
| 52-Week High | 0.575 |
| 52-Week High Chg | -73.02% |
| 52-Week Low | 0.252 |
| 52-Week Low Chg | +24.52% |
| S&P 500 52-Week Chg | 8.96% |
According to market data, Enzo Biochem, Inc. (ENZ) stock's recent performance metrics show that over the last month, ENZ is -36.45%, with a Year-to-Date (YTD) performance of -56.07%. Over the past year, the stock has seen a N/A change. These figures summarize ENZ's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 0.49 | 0.52 | 0.575 | 0.575 | 0.575 | N/A |
| Low | 0.3 | 0.252 | 0.252 | 0.252 | 0.252 | N/A |
| Performance | +20.32% | -36.45% | -52.81% | -72.23% | - | -56.07% |
According to current financial data, ENZ stock's P/E (TTM) ratio is -2.14, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ENZ, including P/S (0.82), P/B (0.38), and P/FCF (-1.09), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ENZ | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.14 | -1.23 | 33.43 | 32.59 |
| P/S (TTM) | 0.82 | 3.71 | 19.05 | 5.98 |
| P/B (TTM) | 0.38 | 0.14 | -1.4 | 5.45 |
| P/FCF (TTM) | -1.09 | 159.37 | -118.45 | 31.94 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep